Westhampton Capital, LLC Abb Vie Inc. Transaction History

Westhampton Capital, LLC

$196 Million
Q3 2024

A detailed history of Westhampton Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Westhampton Capital, LLC holds 8,809 shares of ABBV stock, worth $1.58 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

8,809

Previous 8,809 -0.0%

Holding current value

$1.58 Million

Previous $1.51 Million 15.17%

% of portfolio

0.89%

Previous 0.82%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$154.79 - $180.76 $154,790 - $180,760	1,000 Added 12.81%	8,809 $1.51 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $119,865 - $136,575	-750 Reduced 8.76%	7,809 $1.42 Million
Q4 2023 Jan 19, 2024	SELL	$137.6 - $154.97 $238,736 - $268,872	-1,735 Reduced 16.85%	8,559 $1.33 Million
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $10,019 - $11,598	-75 Reduced 0.72%	10,294 $1.53 Million
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $8,613 - $10,718	-65 Reduced 0.62%	10,369 $1.4 Million
Q1 2023 Apr 14, 2023	BUY	$144.61 - $166.54 $1,446 - $1,665	10 Added 0.1%	10,434 $1.66 Million
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $18,671 - $22,392	135 Added 1.31%	10,424 $0
Q3 2022 Oct 26, 2022	BUY	$134.21 - $153.93 $26,842 - $30,786	200 Added 1.98%	10,289 $1.38 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $5,504 - $6,998	40 Added 0.4%	10,089 $1.55 Million
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $6,598 - $8,187	50 Added 0.5%	10,049 $1.63 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $93,464 - $118,259	-870 Reduced 8.0%	9,999 $1.35 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $29,792 - $33,818	280 Added 2.64%	10,869 $1.17 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $47,344 - $52,744	450 Added 4.44%	10,589 $1.19 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $406,642 - $447,664	3,975 Added 64.49%	10,139 $1.1 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $17,305 - $23,364	215 Added 3.61%	6,164 $660,000
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $87,971 - $103,249	1,024 Added 20.79%	5,949 $521,000
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $48,057 - $64,307	655 Added 15.34%	4,925 $484,000
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $75,465 - $114,414	1,170 Added 37.74%	4,270 $325,000
Q3 2019 Oct 16, 2019	SELL	$62.98 - $75.72 $44,086 - $53,004	-700 Reduced 18.42%	3,100 $235,000
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $249,660 - $319,124	3,800 New	3,800 $276,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westhampton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westhampton Capital, LLC with notifications on news.

Account

Westhampton Capital, LLC Abb Vie Inc. Transaction History